BDC Capital

Founded in 1953, BDC Capital is a Canadian investment firm specializing in growth and expansion financing. It focuses on information technology, technology, energy, cleantech, and healthcare sectors across Canada.

Steven Abrams

Partner

Dinar Ahmed

Principal

Phil Anzarut

Partner

Réjean Asselin

Assistant Vice President, Portfolio Management - Growth and Transition Capital

Lenka Baloghova

Associate

Amine Benmoussa

Principal

Disha Bhargav

Associate

Jeremy Billan

Partner, Growth Equity Partners

Ela Borenstein

Vice President

Dominique Bélanger

Managing Partner

Geoff J. Catherwood

Partner

Sara Cavalluzzi

Associate

Olivier Côté

Associate

Kristina D’Amico

Director, Fund Investments

Nabil El Asraoui

Associate

Jack Fraser

Partner

Jonathan Goodkey

Principal

Nicolas Gravel

Partner

Saif Hashmi

Principal

Vivian Kan

Partner

Karim Kennedy

Director - Cleantech Practice

Leonard Kofman

Partner, Intellectual Property-Backed Financing

Siddartha Krishnan

Partner

Meryeme Lahmami

Associate

Charles Lespérance

Partner

Sandy Li

Associate

Mark Lunick

Senior Director, Growth and Transition Capital

Guillaume Mercier

Partner

Simon Mills

Director, Growth and Transition Capital

Claude Miron

Managing Partner

Alison Nankivell

Vice President

Katherine Nicanorova

Associate

Michael Notto

Partner, Growth Equity Partners

Jérôme Nycz

Vice President

Thomas Park

Partner

Jean-Philippe Poissant

Managing Director, Growth and Transition Capital

Salman Qadir

Senior Associate

Andrianiaina Rajaobelina

Principal

Karl Reckziegel

Vice President

Joseph Regan

Managing Partner

Lally Rementilla

Managing Partner, IP-Backed Financing

Susan Rohac

Managing Partner, Climate Tech Fund

Paul Ryan

Senior Director

Victor Scutaru

Managing Director

Robert Simon

Managing Partner

Matt Stanley

Partner, Climate Tech Fund

Stephanie Tadros

Associate

Zoltan Tompa

Senior Partner

Maxime Tourangeau

Partner, Growth Equity

Ron Warburton

Managing Partner

Brian Whiteway

Senior Director, Growth and Transition Capital

Angelo Zeni

Managing Director, Growth and Transition Capital

Past deals in Montreal

Félix & Paul Studios

Venture Round in 2024
Felix & Paul Studios, founded in 2013 and based in Montreal, Canada, specializes in the production of cinematic virtual reality experiences. The studio, led by directors and visual artists Félix Lajeunesse and Paul Raphaël, has established a reputation for its pioneering approach to virtual reality storytelling. It has developed a proprietary 3D 360º camera and corresponding software that set industry standards for quality in VR filmmaking. The studio creates both original content and collaborates with existing intellectual properties, offering audiences deeply immersive experiences that evoke strong emotional responses. Notable projects include collaborations with Oculus, Universal Studios, and Cirque du Soleil Media, showcasing the studio's commitment to high-quality, innovative storytelling in virtual reality. With a dedicated team of artists, software developers, and engineers, Felix & Paul Studios continues to lead the evolution of this emerging medium.

Puzzle Medical Devices

Series A in 2023
Puzzle Medical Devices develops innovative heart pump solutions to treat advanced heart failure. Its flagship product, ModulHeart, is a modular percutaneous device designed to reduce cardiac afterload and improve renal perfusion. The device's unique design enables safe percutaneous implantation, supporting both renal and cardiac function with low risk of complications. Puzzle Medical has successfully completed its first-in-human study, demonstrating improvements in cardiac and kidney function.

Vention

Series C in 2022
Vention is a cloud-based digital manufacturing platform that enables engineers and manufacturing professionals to design, order, and assemble custom factory equipment in days. It features a 3D Machine Builder with a library of modular structural, motion, and control components, including T-slot aluminum extrusion systems, and supports design, simulation, and ordering directly in a web browser. Its AI-enabled 3D constraints help optimize layouts and ensure feasible configurations, while the platform integrates design, programming, simulation, ordering, and commissioning in a single digital environment. Vention serves both experienced automation specialists and first-time designers, streamlining the creation of automated equipment for applications such as robot cells, tooling, conveyors, and other factory automation.

Talent.com

Series B in 2022
Talent.com is a platform that centralizes jobs available on companies'​ career websites, staffing agencies, or job boards. The company was founded in 2020 and is headquartered in Montreal, Quebec, Canada.

Aifred Health

Seed Round in 2020
Aifred Health Inc. is a Montreal-based company that specializes in developing a deep-learning clinical decision support tool aimed at enhancing personalized medicine in psychiatry. Founded in 2017, Aifred Health addresses the challenges associated with the traditional trial-and-error approach to treatment selection for mental health, particularly in depression, which is a leading cause of medical impairment worldwide. The company's application software provides features such as treatment prediction, interpretability, and patient data tracking, enabling physicians to make informed decisions tailored to individual patients. By processing de-identified data, Aifred Health's AI model facilitates personalized therapeutic choices, thereby improving the likelihood of effective treatment outcomes for patients who often do not respond to initial interventions.

Hopper

Venture Round in 2020
Founded in 2007, Hopper is a Montreal-based company that develops a mobile application using big data to predict and analyze airfares and accommodations. It provides travel recommendations and notifies users when prices are at their predicted lowest points.

Sheertex

Seed Round in 2019
Founded in Montreal, Canada in 2017, Sheertex specializes in the manufacture and sale of women's tights, utilizing advanced polymer fiber technology to ensure durability and comfort. The company also offers a range of products for men and women, including masks and shorts.

Hopper

Series D in 2018
Founded in 2007, Hopper is a Montreal-based company that develops a mobile application using big data to predict and analyze airfares and accommodations. It provides travel recommendations and notifies users when prices are at their predicted lowest points.

NestReady

Venture Round in 2018
Founded in 2012, NestReady is a Montreal-based company that develops a real estate technology marketplace. Its platform integrates all stages of the home buying experience for mortgage lenders and homebuyers, enabling relationship building with customers, tracking client progress, increasing conversions, and reducing customer acquisition costs.

GSM Project

Venture Round in 2018
GSM Project Inc. is a design and production firm specializing in exhibitions for museums and observation decks. Founded in 1958 and headquartered in Montreal, Canada, with additional offices in Singapore and Dubai, the company provides a comprehensive range of services that include strategy and planning, research, content creation, design, technical development, project management, and operational support. With an internal multidisciplinary team, GSM Project collaborates with various partners from industries such as branding, science centers, and real estate development to meet the evolving demands of exhibition design. Their focus is on creating immersive and educational visitor experiences, allowing clients worldwide to effectively engage their audiences.

Keatext

Seed Round in 2018
Keatext is a Montreal-based technology company that provides an AI-powered text analytics platform to synthesize customer feedback from multiple channels including surveys, online reviews, chat logs, social media, and support tickets. Using natural language processing, the platform consolidates data into a single view to surface actionable insights, helping businesses understand what customers care about, identify improvement opportunities, and make data-driven decisions to enhance customer experience and related outcomes.

Element AI

Series A in 2017
Element AI is an artificial intelligence company that develops and delivers AI solutions for organizations to identify opportunities to deploy AI and machine learning. It operates an AI as a Service platform that enables businesses to launch and scale AI initiatives in partnership with large corporations. The company maintains an in-house research and development laboratory to advance AI technologies and their deployment in computing infrastructure. Element AI serves industries including insurance, banking and capital markets, manufacturing, logistics, retail, and consumer packaged goods. Founded in 2016 and headquartered in Montreal with an additional office in Toronto, it combines software products, services, and tools that help clients operationalize AI, augment decision-making, and improve business performance. Element AI also maintains collaborations with academia and engages in policy discussions related to technology's societal impact, while acting as an integrator to help organizations adopt and implement AI solutions.

Dialogue Health Technologies

Seed Round in 2017
Dialogue Health Technologies operates a comprehensive virtual care platform that provides employee wellness and health solutions for Canadian employers. Founded in 2016 and based in Montreal, the company offers a variety of services aimed at enhancing employee engagement and health. Its platform allows employees to interact with healthcare professionals, including nurses and doctors, for support in physical and mental health. Additionally, the platform facilitates care navigation, medication delivery, and referrals to specialists. By empowering employees to take charge of their health, Dialogue Health Technologies helps businesses create a healthier workforce, leading to increased productivity and overall employee satisfaction.

Sofdesk

Series A in 2017
Sofdesk Inc. is a software company based in Montreal, Canada, specializing in sales acceleration solutions for the solar and roofing industries. Founded in 2013, Sofdesk develops intuitive web applications designed to help small to medium-sized companies enhance their infrastructure and streamline operations. Its primary products include SolarGraf, which assists solar installers in generating leads and proposals, and RoofGraf, which aids roofing companies in sourcing new business opportunities. By offering a comprehensive suite of tools for project management, automation, and advanced quoting, Sofdesk enables its clients to reduce operational costs and improve their overall efficiency in a competitive market.

Next AI

Venture Round in 2017
NextAI is an accelerator and founder development program based in Montréal and Toronto, designed for early-stage AI-enabled startups. It targets exceptional teams and individuals from around the globe who aim to commercialize AI research and establish global enterprises. As an innovation hub, NextAI leverages Canada's strong position in artificial intelligence to provide these startups with essential resources, including capital, mentorship, education, and a robust network of business leaders and entrepreneurs. Participating teams can access up to $200,000 in funding, guidance from renowned faculty and scientists, and state-of-the-art AI tools, all aimed at fostering disruptive innovation in various industries.

Hopper

Series C in 2016
Founded in 2007, Hopper is a Montreal-based company that develops a mobile application using big data to predict and analyze airfares and accommodations. It provides travel recommendations and notifies users when prices are at their predicted lowest points.

Transit

Seed Round in 2016
Transit is a mobile app intended to help its users navigate their cities. Transit simplifies local travel in 125 cities worldwide. Upon launch, the bright, intuitive interface shows all nearby transportation options and departures. Users can plan trips, set reminders, and get notifications about disruptions. Plus, Transit also integrates other sustainable transport modes -- bike sharing, car sharing and Uber -- so users can determine the best way to get from A to B. With millions of active users in the US and Canada, Transit has emerged as the leading urban transit app in North America. The company is based in Montreal, Quebec.

Paper

Seed Round in 2016
Paper is an educational technology company that provides personalized tutoring support for students. Its platform offers live help, essay feedback, real-time reports, and intervention tools to facilitate learning and assist teachers. Founded in 2014, Paper is headquartered in Montreal, Canada.

Transit

Seed Round in 2015
Transit is a mobile app intended to help its users navigate their cities. Transit simplifies local travel in 125 cities worldwide. Upon launch, the bright, intuitive interface shows all nearby transportation options and departures. Users can plan trips, set reminders, and get notifications about disruptions. Plus, Transit also integrates other sustainable transport modes -- bike sharing, car sharing and Uber -- so users can determine the best way to get from A to B. With millions of active users in the US and Canada, Transit has emerged as the leading urban transit app in North America. The company is based in Montreal, Quebec.

Hopper

Venture Round in 2015
Founded in 2007, Hopper is a Montreal-based company that develops a mobile application using big data to predict and analyze airfares and accommodations. It provides travel recommendations and notifies users when prices are at their predicted lowest points.

Execution Labs

Series A in 2014
Execution Labs Inc. is a Montreal-based company founded in 2012 that invests in small to medium-sized independent game studios across the Americas and Europe. The company specializes in supporting developers of downloadable titles for mobile devices, PCs, and consoles. Initially operating as a hybrid incubator and accelerator, Execution Labs has transitioned to a model focused on providing hands-on guidance and resources to a network of established studios rather than seeking new investments. By leveraging the expertise of a dedicated in-house team and volunteer mentors, the company aims to enhance the entrepreneurial skills of game developers, thereby fostering their growth as business leaders in the competitive gaming industry.

Kitfox Games

Pre Seed Round in 2014
Kitfox Games is an independent game studio based in Montreal, focused on developing and publishing high-quality, narrative-driven games. The company is known for its commitment to creating immersive experiences that encourage exploration and discovery of new worlds. With a diverse team hailing from various countries, Kitfox Games emphasizes collaboration and creativity in its projects. Their portfolio includes titles such as Shattered Planet and Moon Hunters, which provide players with engaging stories and unique gameplay experiences across different gaming consoles.

Bunch

Venture Round in 2013
Bunch is a Canadian social networking company headquartered in Montreal. It operates a mobile-based platform that connects users with shared interests by facilitating topic-specific discussions. Users can join up to three 'bunches', each centered around a particular subject, and engage with others by sharing content or comments related to these topics. Bunch aims to add depth to social media by fostering meaningful conversations among like-minded individuals. The platform is free to use and accessible via the App Store across North America.

reelyActive

Seed Round in 2012
Founded in Montreal, Canada in 2012, reelyActive develops an open-source software platform that collects and streams real-time location data of radio-identifiable devices in physical spaces. This technology improves operational efficiency and enhances human experiences for businesses.

Execution Labs

Seed Round in 2012
Execution Labs Inc. is a Montreal-based company founded in 2012 that invests in small to medium-sized independent game studios across the Americas and Europe. The company specializes in supporting developers of downloadable titles for mobile devices, PCs, and consoles. Initially operating as a hybrid incubator and accelerator, Execution Labs has transitioned to a model focused on providing hands-on guidance and resources to a network of established studios rather than seeking new investments. By leveraging the expertise of a dedicated in-house team and volunteer mentors, the company aims to enhance the entrepreneurial skills of game developers, thereby fostering their growth as business leaders in the competitive gaming industry.

Alethia Biotherapeutics

Series B in 2012
Alethia Biotherapeutics, Inc. is a biotechnology company based in Montreal, Canada, founded in 2002. It specializes in the discovery and development of monoclonal antibody-based therapeutics aimed at treating various forms of cancer, particularly focusing on cancer-associated epithelial-to-mesenchymal transition, ovarian cancer, and cancer-induced bone loss. The company's product portfolio includes Isogranulatimide, a G2 checkpoint inhibitor that enhances the effectiveness of DNA-damaging chemotherapy agents; sCLU, a glycoprotein linked to multiple malignancies; AB-0447, which targets a specific antigen prevalent in over eighty-five percent of ovarian cancer cases; and AB-0440, a protein involved in osteoclast differentiation associated with bone loss. Alethia Biotherapeutics employs patented STAR discovery technology to develop therapeutics that address clinically relevant disease-specific targets, thereby aiding healthcare professionals in managing cancer and its complications.

FounderFuel

Convertible Note in 2012
FounderFuel is a Montreal-based mentor-driven accelerator for technology startups. It operates a four-month program that connects young companies with a network of veteran entrepreneurs, operators, and executives to refine visions, expand networks, and accelerate progress. Founded in 2011 by Real Ventures, the program emphasizes technology ventures, including those leveraging artificial intelligence and machine learning, and provides participants with access to investors and strategic mentors to support early growth.

Alethia Biotherapeutics

Series A in 2010
Alethia Biotherapeutics, Inc. is a biotechnology company based in Montreal, Canada, founded in 2002. It specializes in the discovery and development of monoclonal antibody-based therapeutics aimed at treating various forms of cancer, particularly focusing on cancer-associated epithelial-to-mesenchymal transition, ovarian cancer, and cancer-induced bone loss. The company's product portfolio includes Isogranulatimide, a G2 checkpoint inhibitor that enhances the effectiveness of DNA-damaging chemotherapy agents; sCLU, a glycoprotein linked to multiple malignancies; AB-0447, which targets a specific antigen prevalent in over eighty-five percent of ovarian cancer cases; and AB-0440, a protein involved in osteoclast differentiation associated with bone loss. Alethia Biotherapeutics employs patented STAR discovery technology to develop therapeutics that address clinically relevant disease-specific targets, thereby aiding healthcare professionals in managing cancer and its complications.

Vantrix

Venture Round in 2010
Founded in 2004, Vantrix specializes in optimizing and delivering digital content over networks to connected devices. Its high-performance platform ensures optimal performance, quality, and cost-effectiveness for service providers worldwide.

Leap Medical

Seed Round in 2010
Leap Medical, Inc. engages in designing, developing, manufacturing, and marketing products that provide the earliest possible indicators of a patient's medical condition. The company is based in Montreal, Canada.

Resonant Medical

Venture Round in 2010
Resonant Medical is a Montreal-based company focused on developing, manufacturing, and commercializing 3D ultrasound image-guided adaptive radiotherapy products for cancer treatment. Founded in 2000, the company offers innovative solutions such as the Clarity Breast System for precise guidance in breast treatments, the Clarity Prostate System for non-invasive prostate treatments, and the Multi-Anatomy System for soft tissue anatomy guidance in various applications. These products are designed to enhance radiation therapy planning, verification, and delivery, providing a non-invasive and radiation-free approach that meets the technical and clinical needs of healthcare providers. Resonant Medical serves a range of professionals within cancer treatment centers, including physicians, physicists, therapists, and administrators. In 2010, the company was acquired by Elekta, further solidifying its commitment to advancing patient care in radiation therapy.

Alethia Biotherapeutics

Seed Round in 2008
Alethia Biotherapeutics, Inc. is a biotechnology company based in Montreal, Canada, founded in 2002. It specializes in the discovery and development of monoclonal antibody-based therapeutics aimed at treating various forms of cancer, particularly focusing on cancer-associated epithelial-to-mesenchymal transition, ovarian cancer, and cancer-induced bone loss. The company's product portfolio includes Isogranulatimide, a G2 checkpoint inhibitor that enhances the effectiveness of DNA-damaging chemotherapy agents; sCLU, a glycoprotein linked to multiple malignancies; AB-0447, which targets a specific antigen prevalent in over eighty-five percent of ovarian cancer cases; and AB-0440, a protein involved in osteoclast differentiation associated with bone loss. Alethia Biotherapeutics employs patented STAR discovery technology to develop therapeutics that address clinically relevant disease-specific targets, thereby aiding healthcare professionals in managing cancer and its complications.

Vantrix

Series B in 2007
Founded in 2004, Vantrix specializes in optimizing and delivering digital content over networks to connected devices. Its high-performance platform ensures optimal performance, quality, and cost-effectiveness for service providers worldwide.

Vantrix

Series A in 2005
Founded in 2004, Vantrix specializes in optimizing and delivering digital content over networks to connected devices. Its high-performance platform ensures optimal performance, quality, and cost-effectiveness for service providers worldwide.

Goal Semiconductor

Series A in 2004
Goal Semiconductor is a fabless semiconductor company that designs and develops mixed-signal integrated circuits for the embedded data acquisition market. The company’s products include system-on-a-chip devices used in various applications. Its microcontrollers integrate peripherals into the chips, replacing additional components typically found on circuit boards. Goal Semiconductor offers VERSA MIX, VERSA1, VRS1000, VRS900, VERSA HV100 or 300, VRS540, and VRS700 microcontrollers with minor variations. In addition, the company provides integrated circuit design services such as analog and digital design, physical design and layout, test program development, automated wafer testing, device characterization, and package test. Goal Semiconductor is based in Montréal, Quebec.

Metrowerks

Venture Round in 1999
Founded in Montreal, Canada in 1985, Metrowerks is headquartered in Austin, Texas. It designs, develops, markets, and supports professional software development tools used by programmers to create applications. The company's products cater to four major market segments: desktop Windows® and Macintosh®, embedded proprietary operating systems, real-time operating systems/Windows® CE, and Java technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.